ArticleBMC public health2022
On the role of financial support programs in mitigating the SARS-CoV-2 spread in Brazil.
Article in BMC public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Barriers and facilitators of the implementation of mammography screening in the Brazilian public health system: scoping review.BMC public health · 2025Article
- Impact of emergency financial support program on testing demand, SARS-CoV-2 prevalence, and social isolation during COVID-19 outbreak in Brazil: a quasi-experimental study.BMC public health · 2024Article
- Article
- Barriers to and facilitators of populational adherence to prevention and control measures of COVID-19 and other respiratory infectious diseases: a qualitative evidence synthesis.European respiratory review : an official journal of the European Respiratory Society · 2023Review
- High-risk children and social isolation: the importance of family functioning.Frontiers in psychology · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundDuring 2020, there were no effective treatments or vaccines against SARS-CoV-2. The most common disease contention measures were social distance (social isolation), the use of face masks and lockdowns. In the beginning, numerous countries have succeeded to control and reduce COVID-19 infections at a high economic cost. Thus, to alleviate such side effects, many countries have implemented socioeconomic programs to fund individuals that lost their jobs and to help endangered businesses to survive.
methodsWe assess the role of a socioeconomic program, so-called "Auxilio Emergencial" (AE), during 2020 as a measure to mitigate the Coronavirus Disease 2019 (COVID-19) outbreak in Brazil. For each Brazilian State, we estimate the time-dependent reproduction number from daily reports of COVID-19 infections and deaths using a Susceptible-Exposed-Infected-Recovered-like (SEIR-like) model. Then, we analyse the correlations between the reproduction number, the amount of individuals receiving governmental aid, and the index of social isolation based on mobile phone information.
resultsWe observed significant positive correlation values between the average values by the AE and median values of an index accounting for individual mobility. We also observed significantly negative correlation values between the reproduction number and this index on individual mobility. Using the simulations of a susceptible-exposed-infected-removed-like model, if the AE was not operational during the first wave of COVID-19 infections, the accumulated number of infections and deaths could be 6.5 (90% CI: 1.3-21) and 7.9 (90% CI: 1.5-23) times higher, respectively, in comparison with the actual implementation of AE.
conclusionsOur results suggest that the AE implemented in Brazil had a significant influence on social isolation by allowing those in need to stay at home, which would reduce the expected numbers of infections and deaths.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.